Showing results (1671-1680 of 1,933) with videos related to

Sort By:
Pageof 194
Nature Medicine|February 20, 2024
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease riskMarc Ferrell, Zeneng Wang, James T Anderson, et al.
Plos One|September 28, 2020
In-field bioreactors demonstrate dynamic shifts in microbial communities in response to geochemical perturbationsRegina L Wilpiszeski, Caitlin M Gionfriddo, Ann M Wymore, et al.
JCI Insight|September 14, 2021
Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancerMegan L Kruse, Mona Patel, Jeffrey McManus, et al.
Genome Announcements|January 11, 2014
Genome Sequence of Escherichia coli O157:H7 Strain 2886-75, Associated with the First Reported Case of Human Infection in the United StatesFatemeh Sanjar, Tracy H Hazen, Sadiq M Shah, et al.
Cardiovascular Research|August 5, 2021
Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosisMarco Witkowski, Mario Witkowski, Julian Friebel, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2014
Rapid detection of Enterococcus spp. direct from blood culture bottles using Enterococcus QuickFISH method: a multicenter investigationMelissa K Deck, Erica S Anderson, Rebecca J Buckner, et al.
Nature Communications|August 6, 2024
Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptorsPrasenjit Prasad Saha, Valentin Gogonea, Wendy Sweet, et al.
Iscience|August 14, 2024
Oral Anaerobutyricum soehngenii augments glycemic control in type 2 diabetesIlias Attaye, Julia J Witjes, Annefleur M Koopen, et al.
Plos One|July 9, 2011
Towards a rigorous network of protein-protein interactions of the model sulfate reducer Desulfovibrio vulgaris HildenboroughSwapnil R Chhabra, Marcin P Joachimiak, Christopher J Petzold, et al.
American Heart Journal|August 17, 2004
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen, Kenneth W Mahaffey, Richard C Becker, et al.
Pageof 194